443 related articles for article (PubMed ID: 25456001)
1. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.
Yusuf HR; Hooper WC; Beckman MG; Zhang QC; Tsai J; Ortel TL
J Thromb Thrombolysis; 2014 Oct; 38(3):306-13. PubMed ID: 24464552
[TBL] [Abstract][Full Text] [Related]
3. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
Chiao EY; Engels EA; Kramer JR; Pietz K; Henderson L; Giordano TP; Landgren O
Arch Intern Med; 2009 Feb; 169(4):357-63. PubMed ID: 19237719
[TBL] [Abstract][Full Text] [Related]
4. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
5. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
Desai RJ; Pawar A; Weinblatt ME; Kim SC
Arthritis Rheumatol; 2019 Jun; 71(6):892-900. PubMed ID: 30552833
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism in patients with rheumatoid arthritis.
Kim SC; Schneeweiss S; Liu J; Solomon DH
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism in autoimmune diseases: A comprehensive review.
Menichelli D; Cormaci VM; Marucci S; Franchino G; Del Sole F; Capozza A; Fallarino A; Valeriani E; Violi F; Pignatelli P; Pastori D
Autoimmun Rev; 2023 Nov; 22(11):103447. PubMed ID: 37714419
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
10. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
[TBL] [Abstract][Full Text] [Related]
11. Combined autoimmune cytopenias.
Martino R; Muñiz-Díaz E; Arilla M; Ibáñez M; Altés A; Guanyabens C; Madoz P
Haematologica; 1995; 80(4):305-10. PubMed ID: 7590498
[TBL] [Abstract][Full Text] [Related]
12. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus.
Nossent JC; Keen HI; Preen DB; Inderjeeth CA
Lupus; 2024 Jul; 33(8):787-796. PubMed ID: 38655753
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
Ungprasert P; Tanratana P; Srivali N
Thromb Res; 2015 Nov; 136(5):1013-7. PubMed ID: 26359320
[TBL] [Abstract][Full Text] [Related]
15. Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases: A Population-Based Study.
Bleau N; Patenaude V; Abenhaim HA
Clin Appl Thromb Hemost; 2016 Apr; 22(3):285-91. PubMed ID: 25294635
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis.
Barron N; Arenas-Osuna J; Medina G; Cruz-Dominguez MP; González-Romero F; Velásques-García JA; Ayala-López EA; Jara LJ
Clin Rheumatol; 2018 Apr; 37(4):943-948. PubMed ID: 29335897
[TBL] [Abstract][Full Text] [Related]
17. The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink.
Peeters PJ; Bazelier MT; Uitdehaag BM; Leufkens HG; De Bruin ML; de Vries F
J Thromb Haemost; 2014 Apr; 12(4):444-51. PubMed ID: 24502649
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
20. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.
Hsiao YH; Chen YT; Tseng CM; Wu LA; Lin WC; Su VY; Perng DW; Chang SC; Chen YM; Chen TJ; Lee YC; Chou KT
Sleep; 2015 Apr; 38(4):581-6. PubMed ID: 25669189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
